Modulation of the number and functions of endothelial progenitor cells by interleukin 1β in the peripheral blood of pigs: involvement of p38 mitogen-activated protein kinase signaling in vitro.
Anrong Mao,Chaoqian Liu,Yan Guo,Dongwei Su,Tianhang Luo,Wenzheng Fu,Hong Zhou,Guoen Fang,Yuan Sheng
DOI: https://doi.org/10.1097/TA.0b013e318265d142
2012-01-01
Journal of Trauma and Acute Care Surgery
Abstract:BACKGROUND: Endothelial progenitor cells (EPCs) have therapeutic potential for the treatment of organ ischemia following trauma or sepsis, frequently associated with inflammatory conditions. We aimed to investigate the effects of interleukin 1 beta (IL-1 beta) on the properties of EPCs and explore its possible relationship with p38 mitogen-activated protein kinase (MAPK). METHODS: EPCs were isolated from peripheral blood of a porcine model and were characterized. Effects of IL-1 beta on cell number, proliferation, migration, adhesion, and angiogenic function of EPCs were evaluated in a time- and dose-dependent manner. The activity of p38 MAPK in EPCs was measured by Western blot. Moreover, the effects of SB203580, a specific p38 MAPK inhibitor, on levels of p38 MAPK phosphorylation and the number and functions of EPCs under IL-1 beta conditions were examined. RESULTS: Incubation of EPCs with IL-1 beta (5 ng/mL) for 5 days and with IL-1 beta (0.05-50 ng/mL) for 48 hours induced a significant reduction in EPC numbers and proliferation, respectively (p < 0.01 vs. control cells). The capacities for migration, adhesion, and angiogenic function of EPCs were also reduced in a time- and dose-dependent manner. IL-1 beta induced dose- and time-dependent activation of p38 MAPK in EPCs. Moreover, inhibition of p38 MAPK by SB203580 significantly increased the total number of EPCs by twofold as compared with the IL-1 beta-alone group (p < 0.01) and blocked the ability of IL-1 beta to impair the functional response of EPCs. CONCLUSION: These results demonstrate that there is a negative cause-effect relationship between IL-1 beta and EPCs. Thus, IL-1 beta inhibits EPC proliferation, migration, adhesion, and tube formation by a mechanism, which involves p38 MAPK signaling in regulating the number and functions of EPCs in vitro. (J Trauma Acute Care Surg. 2012; 73: 1145-1151. Copyright (c) 2012 by Lippincott Williams & Wilkins)